Breast Imaging Reporting & Data System - American College of …
A comprehensive guide providing standardized breast imaging terminology, report organization, assessment structure and a classification system for mammography, ultrasound and MRI of the breast.
Recommendation 1: Extravasation risk is minimized by 1) using angiocatheters over butterflies, 2) performing meticulous intravenous insertion technique (confirming intravenous location by aspirating blood through an inserted
LI-RADS® CT/MRI Radiation TRA v2024 Core ⓒ 2024 American College of Radiology® | All rights reserved
MAGNETIC RESONANCE IMAGING Amount of fibroglandular tissue (FGT) a. Almost entirely fat b. Scattered fibroglandular tissue c. Heterogeneous fibroglandular tissue
0555T Bone strength and fracture risk using finite element analysis of functional data, and bone- mineral density, utilizing data from a computed tomography scan; retrieval and transmission of the scan data 0556T Bone strength and fracture risk using finite element analysis of functional data, and bone- mineral density, utilizing data from a computed tomography scan; assessment of bone
ACR MANUAL ON CONTRAST MEDIA – PREFACE 1 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.It is being published as a web-based document only so it can be updated as frequently as needed.
NOTES 1. Lung-RADSCategory:Each exam should be coded 0-4 based on the nodule with the highest degree of suspicion. 2. Lung-RADSManagement:The timing of follow-up imaging is from the date of the exam being interpreted.
PI-RADS® v2.1 ACR – ESUR – AdMeTech 2019 i PI-RADSv2.1 PI-RADS® Prostate Imaging – Reporting and Data System 2019 Version 2.1
Back to Top 6 OCTOBER 2021 Answer: For the purposes of risk stratification, ascites is defined as fluid extending beyond the cul-de-sac superior to the uterine fundus if the uterus is anteverted or anteflexed, or fluid anterior and superior
10.23 Higher-risk women need supplemental and earlier screening Risk Mammography/ Tomosynthesis MRI* Known genetic mutation or lifetime risk ≥ 20%